| SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE |
Basic
and diluted net loss per share for each of the periods presented are calculated as follows:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended
December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | |
| | |
| | | |
| | | |
| | |
| Basic net loss per share | |
| | | |
| | | |
| | |
| Numerator: | |
| | | |
| | | |
| | |
| Net loss attributable to Uxin Limited | |
| (372,387 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| Deemed dividend to preferred
shareholders due to triggering of a down round feature | |
| (2,060,254 | ) | |
| - | | |
| - | |
| Net
loss attributable to ordinary shareholders | |
| (2,432,641 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | |
| Number of ordinary shares outstanding at the
beginning of the period | |
| 1,410,826,415 | | |
| 56,381,481,399 | | |
| 56,395,662,999 | |
| Weighted average number of ordinary shares issued | |
| 754,367,970 | | |
| 6,137,059 | | |
| 4,906,843,295 | |
| Weighted average number of vested penny options | |
| 20,169,250 | | |
| 29,241,834 | | |
| 22,577,368 | |
| Weighted average number
of unissued shares relating to the Performance Awards (Note 17) | |
| - | | |
| 327,882,355 | | |
| 1,431,232,500 | |
| Weighted average number of ordinary shares
outstanding - basic | |
| 2,185,363,635 | | |
| 56,744,742,647 | | |
| 62,756,316,162 | |
| | |
| | | |
| | | |
| | |
| Net loss per share attributable
to ordinary shareholders, basic | |
| (1.11 | ) | |
| (0.00 | ) | |
| (0.00 | ) |
| | |
| | | |
| | | |
| | |
| Diluted net loss per share | |
| | | |
| | | |
| | |
| Numerator: | |
| | | |
| | | |
| | |
| Diluted
net loss attributable to ordinary shareholders | |
| (2,432,641 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | |
| Weighted average number of ordinary shares
outstanding – diluted | |
| 2,185,363,635 | | |
| 56,744,742,647 | | |
| 62,756,316,162 | |
| | |
| | | |
| | | |
| | |
| Net loss per share attributable
to ordinary shareholders, diluted | |
| (1.11 | ) | |
| (0.00 | ) | |
| (0.00 | ) |
|
| SCHEDULE OF POTENTIAL ORDINARY SHARES THAT ARE ANTI-DILUTIVE AND EXCLUDED FROM THE CALCULATION OF DILUTED NET LOSS PER SHARE |
SCHEDULE OF POTENTIAL ORDINARY SHARES THAT ARE ANTI-DILUTIVE AND EXCLUDED FROM THE CALCULATION OF DILUTED NET LOSS PER SHARE
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
| | | |
| | | |
| | |
| Unissued shares relating to the
Performance Awards (Note 17) | |
| - | | |
| 594,838,632 | | |
| - | |
| Forward contract | |
| - | | |
| 216,847,736 | | |
| 964,746,183 | |
| Senior convertible preferred shares | |
| 1,288,858,108 | | |
| - | | |
| - | |
| Outstanding weighted average share options | |
| 13,605,459 | | |
| 9,937,549 | | |
| 28,071,729 | |
| Total | |
| 1,302,463,567 | | |
| 821,623,917 | | |
| 992,817,912 | |
| Anti-dilutive securities excluded from the calculation of diluted net loss per share | |
| 1,302,463,567 | | |
| 821,623,917 | | |
| 992,817,912 | |
|